At the last ERA-EDTA Vienna Congress, during the Opening Ceremony (May 21, 2016), the following ERA-EDTA Awards were given:

ERA-EDTA Award for Outstanding Educational Contributions to Nephrology
Rosanna Coppo (Italy)
Rosanna Coppo

Professor Rosanna Coppo is the recipient of 2016 ERA-EDTA Award for Outstanding Contributions to Nephrology.
Professor Rosanna Coppo graduated in medicine at the University of Turin in 1973 and in nephrology in 1975. From 1980 to 2013 she was a Professor at Post-Graduate  School of Nephrology and from 1989 to 2015 a Professor at Post-Graduate  School of Pediatrics both at University of Turin.
Professor Rosanna Coppo is author and co-author of 284 publications recorded in PubMed, author of 56 Chapters in books, including Rheumatology and the kidney, Pediatric Nephrology, European Pediatric Nephrology handbook; Oxford Textbook of Clinical Nephrology, Pediatric Nephrology 2015.
Professor Coppo is widely recognized speaker at International and National Congresses where she shares her knowledge and experience. She was Invited Speaker in Louvain, Cleveland, New York, Istanbul, Lisbon, Heidelberg and Tokyo and others.
Among her many contributions to ERA-EDTA education was one of her priorities. From 2003 – 2009 she was responsible for Continuing Medical Education (CME) programme. In this period educational programme became one of the cornerstone and brand of ERA-EDTA. Personally organized many courses also together with ERA-EDTA Working Group chaired by her – the Immunonephrology Working Group. She chaired the Scientific Committee of the 2013 ERA-EDTA Congress in Istanbul as well as scientific committees of other associations.
Professor Coppo contributed to education also by working in editorial boards of many journals: NDT, CJASN, Paediatric Nephrology, Journal of Nephrology and Giornale Italiano di Nefrologia.
During her successful career Professor Coppo trained numerous nephrologists and pediatricians but also she contributed to establish the education of nephrology on institutional level what makes this award very well deserved.


ERA-EDTA Award for Outstanding Basic Science Contributions to Nephrology
Pierre Ronco (France)
Pierre Ronco

Professor Pierre Ronco is the recipient of 2016 ERA-EDTA Award for Outstanding Basic Science Contributions to Nephrology. He studied and graduated in Medicine and Immunology at Pierre et Marie Curie University and University Paris 7 in 1973 and 1980.  Since 1986 he is Professor of Nephrology at Pierre et Marie CurieUniversity. Since 1998 he is Director of INSERM/UPMC Unit 1155 focusing on: Rare and common kidney diseases, matrix remodeling and tissue repair.
Main fields of interest of Professor Ronco as clinician and research scientist are pathophysiology and treatment of immunological diseases of the kidney. Professor Ronco together with Dr. Kerjaschki and Dr. Farqhuar contributed to the characterization of megalin, the target antigen of pathogenic antibodies in Heymann’s nephritis, a rat experimental model of membranous nephropathy (MN). They also identified neutral endopeptidase (NEP) and dipeptidylpeptidase IV (DPPIV) as new antigens involved in MN in the rabbit and the mouse, respectively, and they put forward the hypothesis that these antigens could be implicated in the human disease. This led to identifying a novel feto-maternal disease in which a genetic defect in the mother leads to development of MN in her fetus. The identification of NEP paved the way for that of M-type phospholipase A2 receptor (PLA2R), the first podocyte antigen identified in autoimmune idiopathic MN by D. Salant’s group. Next aim of the  Professor Ronco and his collaborators was to identify predisposing genes in idiopathic MN. They found that the disease was associated with allele variants of HLA-DQA1 and PLA2R1 which confirmed the implication of PLA2R antigen by a pangenomic (GWAS) approach and suggested presentation of relevant epitopes by HLA-DQA1 variants to the immune system. Next steps were developing serological tests for measurement of anti-PLA2R antibodies and showing that detection of PLA2R antigen in biopsies was more sensitive than serology and enabled retrospective diagnosis of PLA2R-related MN in archival biopsies. Together with Professor G. Remuzzi’s group  he showed that in patients treated with rituximab, anti-PLA2R titer was a strong and independent predictor of remission and relapse. Additionally he made substantial contributions to the angiotensin-2 related idiotypic network including by crystallographic analysis, the pathophysiology and treatment of renal complications of hematological malignancies and plasma cell dyscrasias, and the role of matrix metalloproteases and matrix proteins in kidney development and disease. Together with his team, Professor Ronco identified a novel autosomal dominant hereditary collagen disease, which he called HANAC for Hereditary Angiopathy with Nephropathy, Aneurysms and Cramps
Besides basic science contributions Professor Ronco is very active among Nephrological Societies. He chaired Scientific Committees of ERA-EDTA Congress in Glasgow and ISN World Congress in Cape Town. Professor Ronco was also the Co-President of ERA-EDTA Congress in Paris (2012).

ERA-EDTA Awards for Outstanding Clinical Contributions to Nephrology 
Christoph Wanner (Germany)
Christoph Wanner

Professor Christoph Wanner is the recipient of 2016 ERA-EDTA Award for Outstanding Clinical Contributions to Nephrology.
Professor Wanner took his education in Medicine in Berlin, Wurzburg, Ferrara, Singapore and Zurich. Since 1994 he is a Professor of Medicine in Division of Nephrology, University of Würzburg.
The main achievements in research field are the design and execution of two landmark trials (4D & EMPA-REG Outcome Studies) impacting on cardiovascular and renal health in type 2 diabetes. Through their results these studies stimulated the field in multiple directions and revolutionized therapy of type 2 diabetics in early and late stages of CKD and on dialysis. The studies on the activated acute phase response predicting outcomes in dialysis patients were forerunners in the field.
Large scope of the above mentioned influence was made within ERA-EDTA bodies. From 2000 to 2006 he served as member of the EBPG Work Group (European Best Practice Guidelines) and participated in the hemodialysis Part I & II guidelines. Until today he serves as ERBP (European Renal Best Practice) executive Board member. Professor Wanner is continuously involved in global guidelines body – KDIGO.
In 2003 he was elected Registry Board Member, transitioning to Chair of the ERA-EDTA Registry in 2009 where he served until 2015. The call for the studies of Rare Diseases, fellowship and PhD programmes brought Registry Research into full bloom and to international visibility. The Clinical Epidemiology Learning and Research Centre emerged during his time and the EQUAL cohort study was designed and initiated in 2012.
Over many years Professor Wanner served as Late Breaking Clinical Trials organizer, in a number of Scientific Programme Committees of the Annual Congresses.


Award for Outstanding Contributions to ERA-EDTA

Raymond Vanholder (Belgium)
Raymond Vanholder

Professor Raymond Vanholder is the recipient of 2016 ERA-EDTA Award for Outstanding Contributions to ERA-EDTA.
Professor Vanholder became ERA-EDTA member in 1983. Since 1985 he serves continuously as speaker and chairman at ERA-EDTA Congresses, organizer of CMEs endorsed by Society and active member of multiple ERA-EDTA bodies. Since 2011 he is a Fellow of ERA-EDTA (FERA).
From 2011 to 2014 he was the President of ERA-EDTA. The main achievements accomplished by ERA-EDTA during his term were: the number of members increased by 10% from 6200 to 7000. 3rd Research Programme call was opened. Over 100 CMEs were organized. 3 new Working Groups were installed (DESCARTES, Diabesity and CKD-MBD) as well as Young Nephrologists’ Platform. An endorsement of EuroPD was announced. ERA-EDTA renewed its website and appeared in social media via Facebook, Twitter, Google+, Youtube and Vimeo. ERA-EDTA journals format has been changed (NDT was reduced in volume, CKJ transformed to open access journal, Follow us was reactivated and Follow-us Flash launched). Also relationships with numerous societies were formalized and improved.
From 2000-2003 Professor Vanholder was member of ERA-EDTA Council. Major accomplishments of ERA-EDTA in that term were: World Congress of Nephrology (WCN) in Berlin, 2003, in collaboration with ISN, moving the Registry to Amsterdam and bringing back financial balance to the Society.
From – 2003 to 2006 he was a member of CME Committee, in 2011 he chaired the Scientific Committee of the ERA-EDTA Congress in Prague. He was and still is a member of Scientific Committees, SAB and many Working Groups.
Since 2015 he chairs European Kidney Health Alliance (EKHA).
Since 1988 he is NDT Reviewer, since 1993 member of the Editorial Board and Subject Editor since 2007. Since the installation of NDT-educational Professor Vanholder is a member of its Editorial Board. He was instrumental in creating European guidelines first among European Best Practice Guidelines
(EBPG) then among European Renal Best Practice (ERBP) serving as a member of both bodies and member of both bodies Boards and finally as chair.
In 2015 Professor Vanholder was elected to the Ethics Committee.
All the above is only a part of Professor Raymond Vanholder’s activities and contributions to ERA-EDTA but it shows that he fully deserves the Award Outstanding Contributions.


Stanley Shaldon Award for Young Investigators

Emilie Cornec-Le Gall (France)
Emilie Cornec-Le Gall

Dr. Emilie Cornec-Le Gall is the recipient of the 2015 Stanley Shaldon Award for Young Investigators.
For this award, the Award Committee chooses among the best young authors of abstracts presented during the past three years at the ERA-EDTA Congresses. After carefully reviewing their curriculum, a shortlist of 2 to 3 candidates is selected by the Award Committee and out of this shortlist, the ERA-EDTA Council selects the winner.
Dr. Le Gall took her medical education in Brest Medical School under the mentorship of Prof. Y Le Meur. Then she had a one year training in molecular genetics in the department of Prof. Claude Férec. Genkyst Study allowed her to work at the liaison between Nephrology and Molecular Genetics while completing her clinical training. The main objective was to describe clinical and molecular genetic factors associated with clinical presentation and progression of ADPKD.
In  2013  Dr. Le Gall initiated  the  GeneQuest  study,  which  aims  to  describe  the clinical  and  molecular  genetics  aspects  of  PKD1  and  PKD2  mutation negative carriers. This study is funded  by  a  national  public  program  (PHRC  interregional  2013)  and  a  grant  awarded  by  the  French Kidney  Foundation  (French  young  investigator  Award  2014).
Currently Dr. Le Gall is working as Post-doctoral Research Fellow in PC Harris lab (ASN fellowship), Division of Nephrology and Hypertension, Mayo Clinic, Rochester MN, USA.
As the winner if the Stalney Shalodon Award Dr. Emilie Cornec-Le Gall will also become an ex-officio member of the Young Nephrologists’ Platform Board.
We are looking forward to the further evolution of her scientific career.

Comment sent. Thank you for your cooperation.